Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 4.240
+0.020 (0.47%)
At close: Dec 5, 2025
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 34.61 million as of December 5, 2025. Its market cap has decreased by -46.13% in one year.
Market Cap
34.61M
Enterprise Value
49.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.24
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 26.85M to 34.61M, an increase of 28.92%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 34.61M | -46.31% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | 184.42M | 226.98% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.71B |
| NEUCA | 3.72B |
| Synektik Spólka Akcyjna | 2.35B |
| Voxel | 1.39B |
| Celon Pharma | 1.13B |
| Selvita | 877.39M |
| Ryvu Therapeutics | 663.55M |
| Centrum Medyczne ENEL-MED | 517.53M |